Multiagent chemotherapy is given, and can result in long term success, particularly in childhood but prognosis is generally poor, particularly in higher stage disease.
ALK+ large B-cell lymphoma
Epstein–Barr virus positive diffuse large B-cell lymphoma, not otherwise specified
EML4-ALK positive lung cancer
Nodular lymphocyte predominant Hodgkin lymphoma
Fibrin-associated diffuse large B-cell lymphoma
Pediatric-type follicular lymphoma
RAS-associated autoimmune leukoproliferative disorder
CD30+ cutaneous T-cell lymphoma